MYELOPROLIFERATIVE NEOPLASMS (MPNS)
Clinical trials for MYELOPROLIFERATIVE NEOPLASMS (MPNS) explained in plain language.
Never miss a new study
Get alerted when new MYELOPROLIFERATIVE NEOPLASMS (MPNS) trials appear
Sign up with your email to follow new studies for MYELOPROLIFERATIVE NEOPLASMS (MPNS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill tested for rare blood cancers
Disease control Recruiting nowThis is a first-in-human study to test the safety and find the right dose of an experimental oral drug called PRT12396 for people with certain rare blood cancers. It will enroll about 100 adults with high-risk polycythemia vera or myelofibrosis. The main goal is to see how well t…
Matched conditions: MYELOPROLIFERATIVE NEOPLASMS (MPNS)
Phase: PHASE1 • Sponsor: Prelude Therapeutics • Aim: Disease control
Last updated Apr 01, 2026 20:11 UTC
-
Massive 5,000-Person study launches to map the journey of rare blood cancers
Knowledge-focused Recruiting nowThis is a long-term observational study aiming to better understand a group of rare, chronic blood cancers called myeloproliferative neoplasms (MPNs). It will follow 5,000 adults in the U.S. who have been diagnosed with an MPN for at least five years, collecting information from …
Matched conditions: MYELOPROLIFERATIVE NEOPLASMS (MPNS)
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated Mar 18, 2026 14:40 UTC